2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …

F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

[PDF][PDF] 2016 ESC/EAS guidelines for the management of dyslipidaemias

MT Cooney, E Bruckert, A Cordero, A Corsini… - European heart …, 2016 - iris.unime.it
The content of these European Society of Cardiology (ESC) and European Atherosclerosis
Society Guidelines has been published for personal and educational use only. No …

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …

Ž Reiner, AL Catapano, G De Backer… - European heart …, 2011 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain …

KK Ray, JJP Kastelein… - European heart …, 2014 - academic.oup.com
Atherosclerotic cardiovascular disease is the most important public health problem of our
time in both Europe and the rest of the world, accounting for the greatest expenditure in most …

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …

AL Catapano, Ž Reiner, G De Backer… - …, 2011 - atherosclerosis-journal.com
Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to
thrombosis is the foremost cause of premature mortality and of disability-adjusted life years …

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

ESCNC Societies, F Mach, C Baigent, MR Taskinen - 2019 - helda.helsinki.fi
Guidelines, Dyslipidaemias, Cholesterol, Triglycerides, Low-density lipoproteins, High-
density lipoproteins, Apolipoprotein B, Lipoprotein (a), Lipoprotein remnants, Total …

Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease

R McPherson, J Frohlich, G Fodor, J Genest - Canadian Journal of …, 2006 - Elsevier
Since the last publication of the recommendations for the management and treatment of
dyslipidemia, new clinical trial data have emerged that support a more vigorous approach to …

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

TJ Anderson, J Grégoire, GJ Pearson, AR Barry… - Canadian Journal of …, 2016 - Elsevier
Since the publication of the 2012 guidelines new literature has emerged to inform decision-
making. The 2016 guidelines primary panel selected a number of clinically relevant …

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult …

J Genest, R McPherson, J Frohlich, T Anderson… - Canadian Journal of …, 2009 - Elsevier
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment
of dyslipidemia and prevention of cardi Page 1 Can J Cardiol Vol 25 No 10 October 2009 567 …

[PDF][PDF] PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016

M Banach, P Jankowski, J Jóźwiak… - Archives of Medical …, 2017 - termedia.pl
Guidelines The Guidelines have been officially approved and supported by the Polish
Society of Family Medicine (PSFM). With the consent of Authors and Editorial Boards of …